Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Korean Guidelines for Interventional Recanalization of Lower Extremity Arteries

  • Kim, Young Hwan (Department of Radiology, Keimyung University College of Medicine) ;
  • Bae, Jae Ik (Mint Radiologic Clinic) ;
  • Jeon, Yong Sun (Department of Radiology, Inha University College of Medicine) ;
  • Kim, Chang Won (Department of Radiology, Pusan National University College of Medicine) ;
  • Jae, Hwan Jun (Department of Radiology, Seoul National University College of Medicine) ;
  • Park, Kwang Bo (Department of Radiology, Sungkyunkwan University College of Medicine) ;
  • Cho, Young Kwon (Department of Radiology, Eulji University College of Medicine) ;
  • Kim, Man Deuk (Department of Radiology, Yonsei University College of Medicine)
  • Received : 2015.03.16
  • Accepted : 2015.04.21
  • Published : 2015.08.01
⟨ Previous Next ⟩

Abstract

Peripheral arterial occlusive disease caused by atherosclerosis can present with intermittent claudication or critical limb ischemia. Proper diagnosis and management is warranted to improve symptoms and salvage limbs. With the introduction of new techniques and dedicated materials, endovascular recanalization is widely performed for the treatment of peripheral arterial occlusive disease because it is less invasive than surgery. However, there are various opinions regarding the appropriate indications and procedure methods for interventional recanalization according to operator and institution in Korea. Therefore, we intend to provide evidence based guidelines for interventional recanalization by multidisciplinary consensus. These guidelines are the result of a close collaboration between physicians from many different areas of expertise including interventional radiology, interventional cardiology, and vascular surgery. The goal of these guidelines is to ensure better treatment, to serve as a guide to the clinician, and consequently, to contribute to public health care.

Keywords

References

  1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007;33 Suppl 1:S1-S75 https://doi.org/10.1016/j.ejvs.2006.09.024
  2. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-2906 https://doi.org/10.1093/eurheartj/ehr211
  3. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-e654 https://doi.org/10.1161/CIRCULATIONAHA.106.174526
  4. National Clinical Guideline Center. Lower limb peripheral arterial disease: diagnosis and treatment. Manchester: National Institute for Health and Clinical Excellence, 2012
  5. Scottish Intercollegiate Guidelines Network. Diagnosis and management of peripheral arterial disease. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, 2006
  6. Abramson BL, Huckell V, Anand S, Forbes T, Gupta A, Harris K, et al. Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary. Can J Cardiol 2005;21:997-1006
  7. Symes JF, Graham AM, Mousseau M. Doppler waveform analysis versus segmental pressure and pulse-volume recording: assessment of occlusive disease in the lower extremity. Can J Surg 1984;27:345-347
  8. Pardo M, Alcaraz M, Ramon Breijo F, Bernal FL, Felices JM, Canteras M. Increased transcutaneous oxygen pressure is an indicator of revascularization after peripheral transluminal angioplasty. Acta Radiol 2010;51:990-993 https://doi.org/10.3109/02841851.2010.504968
  9. Padberg FT, Back TL, Thompson PN, Hobson RW 2nd. Transcutaneous oxygen (TcPO2) estimates probability of healing in the ischemic extremity. J Surg Res 1996;60:365-369 https://doi.org/10.1006/jsre.1996.0059
  10. Collins R, Cranny G, Burch J, Aguiar-Ibanez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007;11:iii-iv, xi-xiii, 1-184
  11. Pinto F, Lencioni R, Napoli V, Petrucci R, Vignali C, Armillotta N, et al. Peripheral ischemic occlusive arterial disease: comparison of color Doppler sonography and angiography. J Ultrasound Med 1996;15:697-704; quiz 705-706 https://doi.org/10.7863/jum.1996.15.10.697
  12. Moneta GL, Yeager RA, Lee RW, Porter JM. Noninvasive localization of arterial occlusive disease: a comparison of segmental Doppler pressures and arterial duplex mapping. J Vasc Surg 1993;17:578-582 https://doi.org/10.1016/0741-5214(93)90158-I
  13. Rieker O, Duber C, Schmiedt W, von Zitzewitz H, Schweden F, Thelen M. Prospective comparison of CT angiography of the legs with intraarterial digital subtraction angiography. AJR Am J Roentgenol 1996;166:269-276 https://doi.org/10.2214/ajr.166.2.8553929
  14. Rubin GD, Schmidt AJ, Logan LJ, Sofilos MC. Multi-detector row CT angiography of lower extremity arterial inflow and runoff: initial experience. Radiology 2001;221:146-158 https://doi.org/10.1148/radiol.2211001325
  15. Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009;301:415-424 https://doi.org/10.1001/jama.301.4.415
  16. Khilnani NM, Winchester PA, Prince MR, Vidan E, Trost DW, Bush HL Jr, et al. Peripheral vascular disease: combined 3D bolus chase and dynamic 2D MR angiography compared with x-ray angiography for treatment planning. Radiology 2002;224:63-74 https://doi.org/10.1148/radiol.2241010415
  17. Kreitner KF, Kalden P, Neufang A, Duber C, Krummenauer F, Kustner E, et al. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR Am J Roentgenol 2000;174:171-179 https://doi.org/10.2214/ajr.174.1.1740171
  18. Bertschinger K, Cassina PC, Debatin JF, Ruehm SG. Surveillance of peripheral arterial bypass grafts with three-dimensional MR angiography: comparison with digital subtraction angiography. AJR Am J Roentgenol 2001;176:215-220 https://doi.org/10.2214/ajr.176.1.1760215
  19. Dorenbeck U, Seitz J, Volk M, Strotzer M, Lenhart M, Feuerbach S, et al. Evaluation of arterial bypass grafts of the pelvic and lower extremities with gadolinium-enhanced magnetic resonance angiography: comparison with digital subtraction angiography. Invest Radiol 2002;37:60-64 https://doi.org/10.1097/00004424-200202000-00002
  20. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial. Radiology 2009;250:586-595 https://doi.org/10.1148/radiol.2501080607
  21. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 2008;36:680-688 https://doi.org/10.1016/j.ejvs.2008.10.007
  22. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 2012;125:130-139 https://doi.org/10.1161/CIRCULATIONAHA.111.075770
  23. Kashyap VS, Pavkov ML, Bena JF, Sarac TP, O'Hara PJ, Lyden SP, et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg 2008;48:1451-1457, 1457.e1-1457.e3 https://doi.org/10.1016/j.jvs.2008.07.004
  24. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934 https://doi.org/10.1016/S0140-6736(05)67704-5
  25. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 2010;51(5 Suppl):52S-68S https://doi.org/10.1016/j.jvs.2010.01.077
  26. Conrad MF, Kang J, Cambria RP, Brewster DC, Watkins MT, Kwolek CJ, et al. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg 2009;50:799-805.e4 https://doi.org/10.1016/j.jvs.2009.05.026
  27. Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011;21:2527-2541 https://doi.org/10.1007/s00330-011-2225-0
  28. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375 https://doi.org/10.1016/S0002-9343(97)00150-2
  29. Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T, et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 2004;62:1-7 https://doi.org/10.5414/CNP62001
  30. ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011;124:1250-1259 https://doi.org/10.1161/CIRCULATIONAHA.111.038943
  31. Kinney TB, Rose SC. Intraarterial pressure measurements during angiographic evaluation of peripheral vascular disease: techniques, interpretation, applications, and limitations. AJR Am J Roentgenol 1996;166:277-284 https://doi.org/10.2214/ajr.166.2.8553930
  32. Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg 2009;23:367-373 https://doi.org/10.1016/j.avsg.2008.08.022
  33. Schmidt A, Ulrich M, Winkler B, Klaeffling C, Bausback Y, Braunlich S, et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 2010;76:1047-1054 https://doi.org/10.1002/ccd.22658
  34. Dalla Paola L, Faglia E. Treatment of diabetic foot ulcer: an overview strategies for clinical approach. Curr Diabetes Rev 2006;2:431-447 https://doi.org/10.2174/1573399810602040431
  35. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989;170(3 Pt 2):921-940 https://doi.org/10.1148/radiology.170.3.2521745
  36. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997;204:87-96 https://doi.org/10.1148/radiology.204.1.9205227
  37. Goode SD, Cleveland TJ, Gaines PA; STAG trial collaborators. Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial). Br J Surg 2013;100:1148-1153 https://doi.org/10.1002/bjs.9197
  38. Harnek J, Zoucas E, Stenram U, Cwikiel W. Insertion of self-expandable nitinol stents without previous balloon angioplasty reduces restenosis compared with PTA prior to stenting. Cardiovasc Intervent Radiol 2002;25:430-436 https://doi.org/10.1007/s00270-002-1860-x
  39. Onal B, Ilgit ET, Yucel C, Ozbek E, Vural M, Akpek S. Primary stenting for complex atherosclerotic plaques in aortic and iliac stenoses. Cardiovasc Intervent Radiol 1998;21:386-392 https://doi.org/10.1007/s002709900285
  40. Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011;53:1728-1737 https://doi.org/10.1016/j.jvs.2011.02.005
  41. Grenacher L, Rohde S, Ganger E, Deutsch J, Kauffmann GW, Richter GM. In vitro comparison of self-expanding versus balloon-expandable stents in a human ex vivo model. Cardiovasc Intervent Radiol 2006;29:249-254 https://doi.org/10.1007/s00270-004-0295-y
  42. Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010;52:1376-1383 https://doi.org/10.1016/j.jvs.2010.04.080
  43. Koizumi A, Kumakura H, Kanai H, Araki Y, Kasama S, Sumino H, et al. Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J 2009;73:860-866 https://doi.org/10.1253/circj.CJ-08-0765
  44. Sharafuddin MJ, Hoballah JJ, Kresowik TF, Sharp WJ, Golzarian J, Sun S, et al. Long-term outcome following stent reconstruction of the aortic bifurcation and the role of geometric determinants. Ann Vasc Surg 2008;22:346-357 https://doi.org/10.1016/j.avsg.2007.12.013
  45. Moise MA, Alvarez-Tostado JA, Clair DG, Greenberg RK, Lyden SP, Srivastava SD, et al. Endovascular management of chronic infrarenal aortic occlusion. J Endovasc Ther 2009;16:84-92 https://doi.org/10.1583/08-2526.1
  46. Kasapis C, Henke PK, Chetcuti SJ, Koenig GC, Rectenwald JE, Krishnamurthy VN, et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2009;30:44-55
  47. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994;14:71-81 https://doi.org/10.1177/0272989X9401400109
  48. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83(2 Suppl):I70-I80 https://doi.org/10.1161/01.CIR.83.1.70
  49. Met R, Van Lienden KP, Koelemay MJ, Bipat S, Legemate DA, Reekers JA. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol 2008;31:687-697 https://doi.org/10.1007/s00270-008-9331-7
  50. Siablis D, Diamantopoulos A, Katsanos K, Spiliopoulos S, Kagadis GC, Papadoulas S, et al. Subintimal angioplasty of long chronic total femoropopliteal occlusions: long-term outcomes, predictors of angiographic restenosis, and role of stenting. Cardiovasc Intervent Radiol 2012;35:483-490 https://doi.org/10.1007/s00270-011-0244-5
  51. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516-521 https://doi.org/10.1148/radiol.2322031345
  52. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31 https://doi.org/10.1016/S1051-0443(07)61397-9
  53. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888 https://doi.org/10.1056/NEJMoa051303
  54. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-2749 https://doi.org/10.1161/CIRCULATIONAHA.107.688341
  55. Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007;116:285-292 https://doi.org/10.1161/CIRCULATIONAHA.107.689141
  56. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009;74:1090-1095 https://doi.org/10.1002/ccd.22128
  57. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-276 https://doi.org/10.1161/CIRCINTERVENTIONS.109.903468
  58. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-338 https://doi.org/10.1097/01.RVI.0000151260.74519.CA
  59. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 2013;61:2417-2427 https://doi.org/10.1016/j.jacc.2013.03.034
  60. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-699 https://doi.org/10.1056/NEJMoa0706356
  61. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008;118:1358-1365 https://doi.org/10.1161/CIRCULATIONAHA.107.735985
  62. Scheinert D. LEVANT I: A prospective randomized trial of a paclitaxel-eluting balloon compared to a non-drug-eluting balloon with and without stenting in patients with diseased femoropopliteal arteries. Washington, DC: Transcatheter Cardiovascular Therapeutics, 2010
  63. Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 2012;5:831-840 https://doi.org/10.1161/CIRCINTERVENTIONS.112.971630
  64. Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, Kastrati A, et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv 2012;5:582-589 https://doi.org/10.1161/CIRCINTERVENTIONS.112.969972
  65. Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol 2013;62:1320-1327 https://doi.org/10.1016/j.jacc.2013.05.079
  66. Shammas NW, Coiner D, Shammas GA, Dippel EJ, Christensen L, Jerin M. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. J Vasc Interv Radiol 2011;22:1223-1228 https://doi.org/10.1016/j.jvir.2011.05.013
  67. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47:975-981 https://doi.org/10.1016/j.jvs.2008.01.005
  68. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 2009;16:251-260 https://doi.org/10.1583/09-2691.1
  69. Antoniou GA, Chalmers N, Kanesalingham K, Antoniou SA, Schiro A, Serracino-Inglott F, et al. Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents. J Endovasc Ther 2013;20:131-144 https://doi.org/10.1583/1545-1550-20.2.131

Cited by

  1. Endovascular Repair of Blunt Popliteal Arterial Injuries vol.17, pp.5, 2015, https://doi.org/10.3348/kjr.2016.17.5.789
  2. Predictors for Better Blood-Flow Restoration of Long-Segmental Below-the-Knee Chronic Total Occlusions after Endovascular Therapy in Diabetic Patients vol.17, pp.6, 2015, https://doi.org/10.3348/kjr.2016.17.6.874
  3. Methodology for Developing Evidence-Based Clinical Imaging Guidelines: Joint Recommendations by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency vol.18, pp.1, 2015, https://doi.org/10.3348/kjr.2017.18.1.208
  4. Increased mortality in octogenarians treated for lifestyle limiting claudication vol.91, pp.7, 2018, https://doi.org/10.1002/ccd.27523
  5. A Glimpse on Trends and Characteristics of Recent Articles Published in the Korean Journal of Radiology vol.20, pp.12, 2019, https://doi.org/10.3348/kjr.2019.0928
  6. Critical appraisal of international guidelines for the screening and treatment of asymptomatic peripheral artery disease: a systematic review vol.19, pp.None, 2015, https://doi.org/10.1186/s12872-018-0960-8
  7. A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery Disease vol.71, pp.4, 2015, https://doi.org/10.1177/0003319719896477
  8. Introducing “Recommendation and Guideline” of the Korean Journal of Radiology vol.22, pp.12, 2015, https://doi.org/10.3348/kjr.2021.0785